Prognostic value of c-Met in colorectal cancer: A meta-analysis

Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS

(2014) Tomokazu Kishiki et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection

(2014) Hirokazu Shoji et al.   CANCER SCIENCE

FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk

(2012) Alexandros Garouniatis et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer?

(2011) Alessandro Inno et al.   Clinical Colorectal Cancer

c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases

(2008) Zhao-Shi Zeng et al.   CANCER LETTERS

The Relative Distribution of Membranous and Cytoplasmic Met Is a Prognostic Indicator in Stage I and II Colon Cancer

(2008) F. Ginty et al.   CLINICAL CANCER RESEARCH

The Prognostic Significance of RON and MET Receptor Coexpression in Patients with Colorectal Cancer

(2008) Chung-Ta Lee et al.   DISEASES OF THE COLON & RECTUM